In 1992, the FDA approved the drug Paroxetine (Paxil)
Only after GSK, the makers of Paxil started advertising a condition defined as "social anxiety disorder" was when their profits have skyrocketed with billions of prescriptions around the world being dispensed. GSK has disclosed information about the dangers of this drug such as severe withdrawals and birth defects.
As a result GSK has had many lawsuits over the years:
Class action lawsuits against Paxil have cost the manufacturers billions in patient compensation. Paxil producer, GlaxoSmithKline, was met with Paxil lawsuits and charges ranging from wrongful death to birth defects. Another charge among the Paxil lawsuits was antitrust claims. GlaxoSmithKline was recently ordered to pay a fine totaling over $3 billion for Paxil lawsuit cases.
Prosecutors allege that the company is guilty of illegal promotion of the medication. Paxil was advertised as being safe and effective for the treatment of depression in children. However, this was done despite the FDA never approving the use of Paxil for anyone under the age of 18.
In 2007, GlaxoSmithKline was requested to submit negative data reports in a Paxil lawsuit case in New York. The company was accused of misrepresenting data for prescribing Paxil to children. Since then, the company has been ordered to contribute any available new data regarding medical problems for the next 10 years.